(Q26851228)

S. F. De Meyer

series ordinal

2

1 reference

language of work or name

1 reference

June 2013

1 reference

Journal of Thrombosis and Haemostasis

published in

1 reference

volume

11 Suppl 1

1 reference

page(s)

2-10

1 reference

How I treat patients with thrombotic thrombocytopenic purpura: 2010

cites work

1 reference

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

21 January 2018

1 reference

Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis

21 January 2018

1 reference

ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan

21 January 2018

1 reference

Berend Houwen Memorial Lecture: ISLH Las Vegas May 2009: the pathogenesis and management of thrombotic microangiopathies

21 January 2018

1 reference

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

21 January 2018

1 reference

Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement

21 January 2018

1 reference

Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice

21 January 2018

1 reference

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients

21 January 2018

1 reference

Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase

21 January 2018

1 reference

ADAMTS13: a new link between thrombosis and inflammation.

21 January 2018

1 reference

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

21 January 2018

1 reference

Unwinding the von Willebrand factor strings puzzle

21 January 2018

1 reference

The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.

21 January 2018

1 reference

Systemic antithrombotic effects of ADAMTS13.

21 January 2018

1 reference

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation

21 January 2018

1 reference

Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy

21 January 2018

1 reference

Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes

21 January 2018

1 reference

ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.

21 January 2018

1 reference

von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke

21 January 2018

1 reference

ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

21 January 2018

1 reference

von Willebrand factor: an emerging target in stroke therapy.

21 January 2018

1 reference

Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice

21 January 2018

1 reference

ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice

21 January 2018

1 reference

ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice

21 January 2018

1 reference

Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.

21 January 2018

1 reference

Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice

21 January 2018

1 reference

The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis

21 January 2018

1 reference

A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.

21 January 2018

1 reference

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

21 January 2018

1 reference

ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences

21 January 2018

1 reference

Inhibition of platelet glycoprotein Ib and its antithrombotic potential

21 January 2018

1 reference

Von Willebrand factor: drug and drug target.

21 January 2018

1 reference

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons

21 January 2018

1 reference

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

The TITAN trial--assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice

21 January 2018

1 reference

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.

21 January 2018

1 reference

A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

21 January 2018

1 reference

Polymorphisms and mutations of ADAMTS13 in the Japanese population and estimation of the number of patients with Upshaw-Schulman syndrome

21 January 2018

1 reference

7 January 2021

A common origin of the 4143insA ADAMTS13 mutation

1 reference

7 January 2021

ADAMTS13 exerts a thrombolytic effect in microcirculation

1 reference

7 January 2021

Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions

1 reference

7 January 2021

1 reference

7 January 2021